Team
Services
Brochures
ABK Office
Areas of expertise
Newsletter Archiv
Sitemap
Team
Dr. Hans-Lothar Arth
Dr. Jennifer Baltes
Dr. Dianne Snowden
Boo Geun KIM, Ph.D.
Dipl.-Chem. Senada Duric
Tianna Dauner, J.D.
M.Sc. Limin Siebert-Su
Dipl.-Ing. Kirstin Bettin
ABK Office
Services
Industrial Property Rights
Patents
Patent Portfolio Management
Trademarks
Trademark Portfolio Management
Utility Models
Design Patents
Plant Variety Protection
Applications Abroad
Translations
License Agreements
Employee Inventors Rights
Oppositions
Nullity Suits
Monitoring
Custom recordal
Expert Opinion
Expert Opinion on Patentability
Infringement Opinion
Validity Opinion
Patent/Trademark Portfolio Valuation
Expert Opinion regarding Scientific Projects
Medical-chemical Opinion
Valuation of Gaps in Property Rights
Investment Opinion
Due Diligence
Search
Patents and Utility Models
State-of-the-art Search
Novelty Search
Legal Status Search
Patent Family Search
Monitoring
Infringement Rights
Nullity Rights
Trademarks/ Tradenames
Search for similar Trademarks
Legal State Search
Family Search
Competitor Monitoring
Collision Monitoring
Orphan Drug
Meaning of Orphan Drug?
Is It possible to acquire Orpan Drug Status?
Orphan Drug application
Correspondence with EMEA and FDA
Combination of Orphan Drug and Patent application
Strategie Consulting
Due Diligence
Financing Rounds
IP-Portfolio-Valuation
Investment Opinion
Use of Patents
Competitor Monitoring
Blocking of Competitors
Orphan Drug and Patent
Employee Training
Tradings regarding Industrial Legal Protection
Launch of On-house Patent Division
Trademark Management
Patent and Trademark Management
Employee Inventors Regulation
Contracts
License Agreements
Know-How-Agreements
Research / Development Contracts
Material transfer agreements
Consulting Agreements
Confidentiality Agreements
Areas of expertise
Brochures
Newsletter Archiv
Links
abk-ip
Validation
orphan-drug
Copyright & Disclaimer
Datenschutzerklärung
Secure Dataroom
Sitemap
